Author

H. Khong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:proteomics· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Ardaseva· 1 shared B. May· 1 shared C. Harmon· 1 shared C. T. Truong· 1 shared D. K. Nguyen· 1 shared D. L. Phan· 1 shared D. Maestrini· 1 shared D. Park· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Ardaseva

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PRE-CLINICAL IMMUNE RESPONSE AND SAFETY EVALUATION OF THE PROTEIN SUBUNIT VACCINE NANOCOVAX FOR COVID-19

T. N. M. Tran, B. May, T. T. Ung, M. K. Nguyen, T. T. Nguyen, V. L. Dinh, T. V. Tran, H. Khong, T. T. Nguyen, H. Q. H. Hua, V. A. Nguyen, T. P. Ha, D. L. Phan, T. A. Nguyen, T. N. Bui, , M. S. Do

This study evaluates the immune response and safety of the protein subunit vaccine Nanocovax in animal models, showing high immunogenicity and no adverse effects.

bioRxiv · Jul 20, 2021 · PreprintImmunology

Evolutionary exploitation of PD-L1 expression in hormone receptor positive breast cancer

J. West, D. Park, C. Harmon, D. Williamson, P. Ashcroft, D. Maestrini, A. Ardaseva, R. Bravo, P. Sahoo, H. Khong, K. Luddy, M. Robertson-Tessi

The paper models how timing of aromatase inhibitor and immune checkpoint inhibitor therapies affects tumor burden and metastatic potential in hormone receptor positive breast cancer.

bioRxiv · Oct 26, 2018 · PreprintCancer Biology